Abstract:While alternative methods for toxicity testing using re-constructed human skin and cornea have been written into guidelines and adopted by regulatory authorities, three-dimensional (3D) liver models are currently applied in the industrial settings for hepatotoxicity screening and prediction. These 3D liver models can recapitulate the architecture, functionality and toxicity response of the native liver, demonstrated by a set of related hallmarks. In this comprehensive review, non-scaffold and scaffold-based methods available for 3D liver model formation are introduced, with an emphasis on their advantages and drawbacks. We then focus on the characteristics of primary human hepatocytes, stem cell derived hepatocyte like cells, and immortalized hepatic cell lines as cell resources for model reconstruction. Primary hepatocytes are generally regarded to be superior to other cell types due to their comparable metabolic profiles to the native liver. Additionally, the application of 3D liver models (mostly liver spheroids) on the evaluation of drug induced liver injury and chronic liver diseases (steatosis, cirrhosis, cholestasis), as well as the potential of nanomaterials to introduce hepatotoxicity are summarized. Finally, the global 3D cell market from 3D liver model manufacturing to the contract service of <i>in vitro</i> hepatotoxicity testing using the models is extensively explored. However, 3D liver models face cultural and regulatory barriers in different countries, and therefore the business development of 3D liver models is not easy. Toxicologists, material scientists, engineers should work together to develop, validate and apply 3D liver models for hepatotoxicity testing under the support from industrial organizations and governmental agencies.

3D culture models to study pathophysiology of steatotic liver disease

Advances in 3D Cell Culture for Liver Preclinical Studies.

Toolbox for creating three-dimensional liver models

Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease

Three-dimensional cell culture model for hepatocytes opens a new avenue of real world research on liver

Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury

Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease

Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress

A Novel 3d Liver Organoid System for Elucidation of Hepatic Glucose Metabolism

Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma

Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis

Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities

Current Research Trends in the Application of In Vitro Three-Dimensional Models of Liver Cells

Three-Dimensional Cell Co-Culture Liver Models and Their Applications in Pharmaceutical Research

Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

Liver organoid as a 3D in vitro model for drug validation and toxicity assessment

Constructing biomimetic liver models through biomaterials and vasculature engineering

Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation

Three-dimensional Culture of Hepatocytes for Prediction of Drug-Induced Hepatotoxicity

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening